Table 4.
Treatments | Dose (mg/kg, p.o.) |
Food intake (g/30 min) |
Plasma GLP-1 (pg/mL) |
Plasma CCK (pg/mL) |
---|---|---|---|---|
Control | – | 1.31 ± 0.06 | 20.0 ± 3.4 | 419 ± 25 |
Chakasaponin II (12) | 25 | 1.19 ± 0.08 | 25.3 ± 4.6 | 681 ± 70** |
50 | 1.02 ± 0.06** | 37.3 ± 9.9* | 702 ± 112** |
Male ddY mice (6 weeks old) were fed a high-fat diet (45 kcal % fat, D12451; Research Diets Inc.) for 7 days before the experiments. Test samples were given orally to the fasted mice 45 min before the mid-light satiety test. The high-fat diet was then given to the mice for 30 min, and the food intake within the 30-min period was measured for each group. A blood sample was collected from the portal vein under anesthesia, and plasma GLP-1 and CCK levels were measured by ELISA kits. Refer to Fig. 6 for abbreviations
Values represent the mean ± SEM (n = 7 or 8)
Significant difference where *p < 0.05 or **p < 0.01 was compared with controls